With the potential for pharmaceutical import tariffs spurring a rush of life sciences investments in the U.S., AbbVie is ...

As Marty Makary nears the end of his first month on the job, the FDA Commissioner sat down for two interviews, offering ...

Boehringer Ingelheim has signed a €500m ($572m) agreement with UK-based biotech Tessellate Bio to co-develop targeted cancer ...

Ingelheim: Boehringer Ingelheim and Tessellate Bio, a precision oncology company, have entered into a research collaboration ...

It is predicted that the size of Korea's bio-health industry market will rank 8th in the world by 2030. As of February this ...